Browsing: HIV/AIDS

Researchers at George Mason University and Tulane National Primate Research Center have developed a groundbreaking HIV-like virus particle that could…

Dr. Kenny Lin discusses the recent addition of clinical decision support for ordering vitamin D tests, emphasizing the need for…

Exploratory analysis links abacavir use to increased cardiovascular risk in HIV patients. Study findings will be presented at the 2024…

Long-acting injectable cabotegravir for HIV prevention deemed safe during pregnancy in global study among cisgender women. Long-acting injectable cabotegravir (CAB-LA)…

Global progress in combating HIV/AIDS has been hindered by funding shortages, rising new infections, and gender disparities according to a…

New HIV drug Lenacapavir could be manufactured for as little as $40, potentially revolutionizing HIV treatment. A new HIV drug,…

Researchers have identified how the COVID-19 virus causes cell death in airway cells, shedding light on disease severity and potential…

UNAIDS chief urges Gilead to expand access to groundbreaking HIV drug to end pandemic. Byanyima emphasizes potential impact and benefits.…

UN warns that political decisions in 2024 will impact the global goal to end AIDS by 2030, despite progress made…

Introduction/background: New recommendations for screening and treatment of anal cancer precursor lesions in people with HIV are based on a…